Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $798.1000 (-0.23%) ($798.1000 - $798.1000) on Fri. Nov. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.18% (three month average) | RSI | 52 | Latest Price | $798.1000(-0.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN advances 1.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(59%) IBB(50%) DIA(47%) SPY(47%) SPLV(46%) | Factors Impacting REGN price | REGN will decline at least -0.59% in a week (0% probabilities). VXX(-50%) VIXM(-30%) TBT(-21%) UNG(-18%) SKYY(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.59% (StdDev 1.18%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $807.46 | 5 Day Moving Average | $816.76(-2.28%) | 10 Day Moving Average | $807.26(-1.13%) | 20 Day Moving Average | $807.46(-1.16%) | To recent high | -5.6% | To recent low | 3% | Market Cap | $84.621b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |